TERM ID="NYU_TERM_1" STRING="Asymptomatic primary hyperparathyroidism" FREQUENCY=1 START=0 END=40 LEMMA="ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="BMD" FREQUENCY=2 START=293 END=296 LEMMA="BONE MINERAL DENSITY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_3" STRING="BMD" FREQUENCY=2 START=452 END=455 LEMMA="BONE MINERAL DENSITY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_4" STRING="PHPT" FREQUENCY=2 START=103 END=107 LEMMA="PRIMARY HYPERPARATHYROIDISM" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_5" STRING="PHPT" FREQUENCY=2 START=188 END=192 LEMMA="PRIMARY HYPERPARATHYROIDISM" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_6" STRING="Primary hyperparathyroidism" FREQUENCY=2 START=74 END=101 LEMMA="PRIMARY HYPERPARATHYROIDISM" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_7" STRING="Primary hyperparathyroidism" FREQUENCY=2 START=74 END=101 LEMMA="PRIMARY HYPERPARATHYROIDISM" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_8" STRING="aPHPT" FREQUENCY=1 START=390 END=395 LEMMA="ASYMPTOMATIC PHPT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_9" STRING="asymptomatic PHPT" FREQUENCY=2 START=371 END=388 LEMMA="ASYMPTOMATIC PHPT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_10" STRING="asymptomatic PHPT" FREQUENCY=2 START=371 END=388 LEMMA="ASYMPTOMATIC PHPT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_11" STRING="bisphosphonates" FREQUENCY=1 START=657 END=672 LEMMA="BISPHOSPHONATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="bone mineral density" FREQUENCY=1 START=271 END=291 LEMMA="BONE MINERAL DENSITY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_13" STRING="calcimimetic agents" FREQUENCY=1 START=702 END=721 LEMMA="CALCIMIMETIC AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="controlled trials" FREQUENCY=1 START=846 END=863 LEMMA="CONTROLLED TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="end-points" FREQUENCY=1 START=882 END=892 LEMMA="END-POINT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="endocrine disorder" FREQUENCY=1 START=121 END=139 LEMMA="ENDOCRINE DISORDER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="hormone replacement" FREQUENCY=1 START=674 END=693 LEMMA="HORMONE REPLACEMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="increased fracture risk" FREQUENCY=1 START=303 END=326 LEMMA="INCREASED FRACTURE RISK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="medical management" FREQUENCY=1 START=55 END=73 LEMMA="MEDICAL MANAGEMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="medical management Primary hyperparathyroidism" FREQUENCY=1 START=55 END=101 LEMMA="PRIMARY HYPERPARATHYROIDISM MEDICAL MANAGEMENT" LEMMA_FREQUENCY=1 HEAD_TERM="Primary hyperparathyroidism" HEAD_LEMMA="PRIMARY HYPERPARATHYROIDISM"
TERM ID="NYU_TERM_21" STRING="medical therapy" FREQUENCY=1 START=548 END=563 LEMMA="MEDICAL THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="medical treatment" FREQUENCY=1 START=921 END=938 LEMMA="MEDICAL TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="reduced bone mineral density" FREQUENCY=1 START=263 END=291 LEMMA="REDUCED BONE MINERAL DENSITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="serum calcium" FREQUENCY=1 START=634 END=647 LEMMA="SERUM CALCIUM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="skeletal effects" FREQUENCY=1 START=211 END=227 LEMMA="SKELETAL EFFECT" LEMMA_FREQUENCY=1
